0001104659-23-110650.txt : 20231023 0001104659-23-110650.hdr.sgml : 20231023 20231023074511 ACCESSION NUMBER: 0001104659-23-110650 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20231023 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20231023 DATE AS OF CHANGE: 20231023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 231338528 BUSINESS ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 450 BEDFORD STREET STREET 2: SUITE 1010 CITY: LEXINGTON STATE: MA ZIP: 02420 8-K 1 tm2328919d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): October 23, 2023

iSpecimen Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-40501		27-0480143
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

450 Bedford Street
Lexington, MA 02420

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (781) 301-6700

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ISPC		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 2.02.

Results of Operations and Financial Condition.

On October 23, 2023, iSpecimen Inc., a Delaware corporation (the “Company”), issued a press release (“Preliminary Earnings Release”) announcing certain preliminary financial and operating results for the quarter ended September 30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. You are advised that financial information in the Preliminary Earnings Release for the quarter ended September 30, 2023 is still under review and may differ once reported in the Company’s unaudited condensed financial statements for the quarter ended September 30, 2023 to be filed by the Company with its Quarterly Report on Form 10-Q on or around November 2, 2023.

The Preliminary Earnings Release contains certain statements and information that speak to the Company’s expectations or predictions of the future. These statements and information may constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements are subject to risks and uncertainties, many of which are beyond the Company’s control, which could cause the Company’s actual results to differ materially from those expressed in or implied by these statements. Please see the Company’s disclosures regarding risk factors and forward-looking statements in its filings with the Securities and Exchange Commission (the “SEC”) (including its Current Reports on Form 8-K, Quarterly Reports on Form 10-Q, and most recent Annual Report on Form 10-K, as amended) for a discussion of the known material factors that could cause the Company’s actual results to differ materially from those indicated or implied by such forward-looking statements.

The information in this Item 2.02 and Exhibit 99.1 attached hereto will not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor will it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 7.01.

Regulation FD Disclosure.

The information set forth under “Item 2.02 Results of Operations and Financial Condition” of this Current Report on Form 8-K with respect to the reporting of certain preliminary financial information of the Company is incorporated into this Item 7.01 by reference.

Additionally, the Company anticipates holding a conference call and audio webcast at 8:30 a.m. Eastern Time on November 2, 2023 (“Earnings Call”) to discuss its third quarter 2023 results. The Company issued a press release on October 23, 2023, providing information on how to access the Earnings Call.

The information in this Item 7.01 will not be deemed “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, nor will it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such filing.

Forward-Looking Statements

This Current Report on Form 8-K may contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. Such forward-looking statements are characterized by future or conditional verbs such as “may,” “will,” “expect,” “intend,” “anticipate,” “believe,” “estimate” and “continue” or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. Such statements are only predictions and the Company’s actual results may differ materially from those anticipated in these forward-looking statements.

There may be events in the future that the Company is not able to accurately predict or control. Factors that may cause such differences include, but are not limited to, those discussed under risk factors in the Company’s Amendment No. 1 to the Annual Report on Form 10-K/A for the year ended December 31, 2022 and other filings filed with the SEC, including the uncertainties associated with the Company’s lack of profitability, its continued capital needs, its lack of a long operating history, its growth strategy, inflation and recession and its impact on the business, Russia’s war with Ukraine and its impact on the operations, its technology development plans, and the regulatory environment in which it operates. Forward-looking statements speak only as of the date they are made. The Company does not assume any obligation to update forward-looking statements as circumstances change. The Company gives no assurance that it will achieve its expectations.

You may access the Company’s SEC filings by visiting SEC’s website at http://www.sec.gov. This Current Report does not constitute an offer or invitation for the sale or purchase of securities or to engage in any other transaction with the Company or its affiliates. The information in this Current Report is not targeted at the residents of any particular country or jurisdiction and is not intended for distribution to, or use by, any person in any jurisdiction or country where such distribution or use would be contrary to local law or regulation.

Item 9.01.

Financial Statements and Exhibits.

(d)	Exhibits.

99.1	Press Release, dated October 23, 2023.
104	Cover Page Interactive Data File

Portions of this report may constitute “forward-looking statements” as defined by federal law. Although the Company believes any such statements are based on reasonable assumptions, there is no assurance that actual outcomes will not be materially different. Additional information about issues that could lead to material changes in the Company’s performance is contained in the Company’s filings with the SEC.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: October 23, 2023

	iSPECIMEN INC.

	By:	/s/ Tracy Curley
		Name: Tracy Curley
		Title: Chief Executive Officer

EX-99.1 2 tm2328919d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

iSpecimen Preannounces Third Quarter 2023 Revenue Increase of 60-70% Sequentially

Management to Host Third Quarter 2023 Conference Call on Thursday, November 2, 2023

LEXINGTON, Mass., October 23, 2023 – iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today preliminary financial results for the third quarter of 2023.

The Company expects third quarter 2023 revenue to be between $2.6 to $2.8 million, representing an increase of between 60% to 70% from second quarter 2023 revenue of $1.63 million. The launch of the iSpecimen’s next-day quote program in the third quarter of 2023 is a key driver of the Company’s higher financial performance for the third quarter of 2023, as it accelerates the biospecimen transaction process, leading to a condensed timeframe from opportunity through fulfillment of purchase orders. Due to this program, iSpecimen has recognized a conversion increase of 122% for quotes to purchase orders for the third quarter of 2023 compared to the blended quarterly average of the prior four quarters, demonstrating the positive impact of this program.

Tracy Curley, CEO of iSpecimen, commented, "In the first half of 2023, we focused largely on improving our operational performance across all departments and creating a line of business structure which leverages resources and the power of our proprietary online marketplace. Given our success in the implementations of these process improvement efforts and specifically with the immediate impact of our recently launched next-day quote program, we are projecting strong third quarter revenue and we expect continued growth to our top-line going forward.”

The iSpecimen management team will host a conference call on Thursday, November 2, 2023 at 8:30 a.m. ET to review its financial and operational results for the third quarter of 2023. To access the call, please use the below information below:

Dial in:	1-888-886-7786 (U.S. Toll Free) or 1-416-764-8658 (International)

Webcast:	https://viavid.webcasts.com/starthere.jsp?ei=1638322&tp_key=9fc5429911

For interested individuals unable to join the conference call, a replay will be available through November 16, 2023, at +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 68130784. An archived version of the webcast will also be available on iSpecimen’s Investor Relations site: https://investors.ispecimen.com/presentations/.

About iSpecimen

iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit www.ispecimen.com.

Forward Looking Statements

This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," “believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risk factors contained in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov. Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements.

Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

Disclaimer Regarding Financial Information

The financial information presented in this press release is based on preliminary, unaudited financial statements prepared by management, for the quarter ended September 30, 2023. Accordingly, such financial information may be subject to change. All information contained in this press release will be qualified with reference to the unaudited financial results for the quarter ended September 30, 2023, which is expected to be released on or before November 2, 2023, and will be posted on www.SEC.gov. While the Company does not expect there to be any material changes to the financial information provided in this press release, any variation between the Company’s actual results and the preliminary financial information set forth herein may be material.

For further information, please contact:

Investor Contacts

KCSA Strategic Communications

Phil Carlson / Erika Kay

iSpecimen@kcsa.com

Media Contacts

KCSA Strategic Communications

Raquel Cona / Shana Marino

iSpecimen@kcsa.com

###

EX-101.SCH 3 ispc-20231023.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 ispc-20231023_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 ispc-20231023_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT

Cover	Oct. 23, 2023
Cover [Abstract]
Document Type	8-K
Amendment Flag	false
Document Period End Date	Oct. 23, 2023
Entity File Number	001-40501
Entity Registrant Name	iSpecimen Inc.
Entity Central Index Key	0001558569
Entity Tax Identification Number	27-0480143
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	450 Bedford Street
Entity Address, City or Town	Lexington
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	02420
City Area Code	781
Local Phone Number	301-6700
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	ISPC
Security Exchange Name	NASDAQ
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false

XML 7 tm2328919d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001558569 2023-10-23 2023-10-23 iso4217:USD shares iso4217:USD shares 0001558569 false 8-K 2023-10-23 iSpecimen Inc. DE 001-40501 27-0480143 450 Bedford Street Lexington MA 02420 781 301-6700 false false false false Common Stock, par value $0.0001 per share ISPC NASDAQ true false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[VE-S9NMQ=%A?B MTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6SU%L, M9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5RMQD)HDU M75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"%'*7?Z/6M M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:PIJ+U$&3H MD<%U!D.LL8DF"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0 ( *4]5U&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T. M@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4 M=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[N MF:*'3^ 5!+ P04 " "E M/5=799!YDAD! #/ P $P %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0 MA:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS> MCQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[ ME.O5,[1R;ZEXZ7D;3?!-FI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8: M8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X M(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA M/UY_ 5!+ 0(4 Q0 ( *4]5U<'04UB@0 +$ 0 " M 0 !D;V-0&UL4$L! A0#% @ I3U75S7+S<7O M*P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0# M% @ I3U75YE&PO=V]R:W-H965T&UL4$L! A0# M% @ I3U75Y^@&_"Q @ X@P T ( !N@P 'AL+W-T M>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% M @ I3U75R0>FZ*M ^ $ !H ( !WQ$ 'AL+U]R96QS M+W=O9(9 0 SP, M !, ( !Q!( %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& / D "0 ^ @ #A0 end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ispecimen.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ispc-20231023.xsd ispc-20231023_lab.xml ispc-20231023_pre.xml tm2328919d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2328919d1_8k.htm": { "nsprefix": "ISPC", "nsuri": "http://ispecimen.com/20231023", "dts": { "schema": { "local": [ "ispc-20231023.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "ispc-20231023_lab.xml" ] }, "presentationLink": { "local": [ "ispc-20231023_pre.xml" ] }, "inline": { "local": [ "tm2328919d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://ispecimen.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2023-10-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2328919d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-10-23", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2328919d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://ispecimen.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001104659-23-110650-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-23-110650-xbrl.zip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�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end